** Shares in Ion Beam Applications (IBA) IBAB.BR rise 2.8%
after it secured a deal with the University of Pennsylvania
Health System for the installation of two ProteusS®ONE proton
therapy solutions
** The Belgian proton therapy group expects the final
contract to be signed later this year
** The Penn Presbyterian Medical Center (PPMC) in
Philadelphia expects to start proton therapy treatments for
patients in 2027
** The shares are on track for their best day since Aug. 16
(Reporting by Olivier Cherfan)
((olivier.cherfan@thomsonreuters.com))